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Abstract: A class of new biodegradable hydrogels based
on poly(ethylene glycol) methacrylate-graft-poly(glutamic
acid) and poly(ethylene glycol) dimethacrylate was synthe-
sized by photoinduced polymerization. Because all the poly-
meric constituents were highly hydrophilic, crosslinking
could be performed in aqueous solutions. This type of
crosslinked hydrogel was prepared by modifying a select
number of acidic side-groups on poly(glutamic acid) with
poly(ethylene glycol) methacrylate. These modified chains
were then crosslinked in the presence of poly(ethylene gly-
col) dimethacrylate under a photoinduced polymerization at
a wavelength of 365 nm. Swelling experiments were con-
ducted to study the crosslinking density, pH-responsive be-
havior, and degradation of the hydrogel. Results showed
that the degree of swelling of this type of hydrogels in-
creased as the crosslinker concentration (or density) was re-
duced. Because of the presence of acidic side chains on poly-
(glutamic acid), swelling behavior was found to be pH-
responsive, increasing at high pH in response to the increase
in the amount of ionized acidic side chains. The degradation
rate of these hydrogels also varied with pH. More rapid
degradation was observed under stronger alkaline condi-
tions because of the hydrolysis of the ester bonds between
the crosslinker and the polymer backbone. Practically useful
degradation rates could be achieved for such hydrogels un-
der physiological conditions. Drug release rates from these
hydrogels were found to be proportional to the protein mo-
lecular weight and the crosslinker density; increasing at
lower protein molecular weight or crosslinker density. The
preliminary findings presented in this article suggest that
this class of biodegradable hydrogels could be an attractive
avenue for drug delivery applications. The specific photoin-
duced crosslinking chemistry used would permit hydrogels
to be synthesized in existence of the entrapped macromo-
lecular drugs including peptides, proteins, and cells. In ad-
dition, the rapid feature of this polymerization procedure
along with the ability to perform hydrogel synthesis and
drug loading in an aqueous environment would offer great
advantages in retaining drug activity during hydrogel syn-
thesis. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 62:
14–21, 2002
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INTRODUCTION
Hydrogels have been used widely as biomaterials
because the high water content renders them biocom-
patible to the body tissues.1–3 As a result, hydrogels
have also been investigated intensively over the last
decade for use in controlled drug release systems and
a variety of other biomedical purposes such as medi-
cal implants, diagnostics, biosensors, bioreactors, and
bioseperators.1–4
Hydrogels are of particular interest in drug delivery
applications because their internal architecture can be
manipulated to dimensions that accommodate the
molecular sizes of the peptide and protein drugs. In
addition, the content, density, and length of the
crosslinking groups can be used to regulate the pore
or mesh size of the swollen hydrogel through which
the entrapped drug traverses and is released.5 As a
consequence, hydrogels can be prepared to possess
tailored internal structures that provide specific re-
lease rates for different drugs. Alternatively, the hy-
drogel matrix can also be manipulated to specifically
retain drugs within the crosslinked network. In this
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case, drug release can be restricted until degradation
of the hydrogel matrix takes place. Because of this
flexibility, hydrogels have been investigated as deliv-
ery systems for a variety of macromolecular drugs
such as peptides, proteins, and genetic-based thera-
peutics.5
Many of the hydrogel systems described in the lit-
erature, including the polyacrylate-based systems,
however, are not biodegradable, rendering them less
suitable as drug delivery platforms.6 To overcome this
shortcoming, a variety of novel chemistries including
the incorporation of biodegradable bonds into the
crosslinked hydrogel network have been investi-
gated.7,8 For instance, Sawhney et al.8,9 reported the
preparation of a bioerodible hydrogel by polymeriza-
tion of the poly(ethylene glycol)-co-poly(-hydroxy
acid) acrylate macromer. Heller and coworkers10 re-
ported the synthesis of crosslinked hydrogel beads by
using unsaturated polyesters. In this case, the release
of bovine serum albumin was facilitated by hydrolysis
and erosion of the polymer network. Recently, syn-
thetic biodegradable polymers based on monomers
that are present in human body, such as poly(-amino
acid)s and poly(-hydroxy acid)s,11,12 have received
considerable interest, simply because both the hydro-
gel itself and its degradation products possess the
least likelihood of eliciting immunogenic responses.
Previously, our group reported on the development
of a biocompatible, biodegradable, and pH-responsive
polypeptide hydrogel based on poly(L-glutamic acid)
(PLG) and poly(ethylene glycol) (PEG).13 However,
because drug entrapment was carried out by a swell-
ing/diffusion process, the amount of high-molecular-
weight drug that could be loaded in the gel was rela-
tively low.13 To resolve this problem, a novel, photo-
initiated crosslinking methodology was introduced
during hydrogel synthesis. In this article, synthesis of
this new class of PLG-PEG hydrogels is described. In
addition, characterization of the swelling and hydro-
lytic degradation properties of these hydrogels as well




PEG with molecular weights of 1000, 2000, and 3400 Da
(PEG-1000, PEG-2000, PEG-3400, respectively), poly(ethyl-
ene glycol) dimethacrylate (PEG-DMA; molecular weight:
536 Da), poly(ethylene glycol) methacrylate (PEG-MA; mo-
lecular weight: 360 Da), methacrylic acid (99%), anhydrous
hydrogen bromide (HBr), tetrahydrofuran (THF), and diox-
ane were purchased from Aldrich Chemical Company (Mil-
waukee, WI). Tetrahydrofuran (THF) and dioxane were re-
fluxed over sodium immediately before use. Insulin (bovine
pancreas grade), albumin (bovine, Fraction V, minimum pu-
rity: 98%), lysozyme (chicken egg white), -benzyl-L-
glutamic acid (BLG), and triphosgene were purchased from
Sigma Chemical Co. (St. Louis, MO).
Methods
The 1H and 13C NMR spectra were obtained by using a
Bruker AMX-300 and AMX-500 NMR spectrometer in deu-
terated chloroform, DMSO-d6, and trifluoroacetic acid, re-
spectively. FT-IR studies were performed on a Nicolet 5-DX
infrared spectrometer by using samples prepared in potas-
sium bromide.
Viscosity measurements of poly(-benzyl-L-glutamate)
(PBLG) were performed in dichloroacetic acid using a Can-
non-Ubbelohde capillary viscometer (Size 75) at 25°C. Mo-
lecular weight was then estimated from intrinsic viscosity
according to the method of Doty using the following equa-
tion11:
[] = 2.78 × 10−5 M0.87 (1)
Typically, the PBLG polymers used in our studies had mo-
lecular weights of approximately 70–80 kDa.
The benzyl group of PBLG was removed by using either
HBr in benzene or 2N NaOH aqueous THF solution. The
molecular weight of the product, PLG, was estimated by
from viscosity measurements in 0.2M NaCl solution at pH
7.3 using the intrinsic viscosity-molecular weight relation-
ship derived from Idelson and Blout14:




Twelve grams (50.6 mmol) of BLG was suspended in 150
mL of anhydrous THF. A solution containing 5.36 g (18
mmol) triphosgene in 50 mL anhydrous THF was slowly
added over a period of 30 min. The mixture was stirred at
50–60°C under nitrogen for about two h until a clear solution
was observed. The solvent was removed under vacuum and
the product was purified by recrystallization using a mixed
solvent of THF and hexane. The yield was 11.21g (84.3%).
The product, BLG-NCA, had a melting point of 89.5–90.5°C
and a 1H NMR (300 MHz, CDCl3) spectrum of:  7.42–7.29
(5H, m, Ar-H), 6.67 (1H, s, NH), 5.16 (2H, s, CH2), 4.41 (1H,
t, CH), 2.62 (2H, t, CH2), 2.29 and 2.15 (2H, m, CH2) ppm.
Poly(-benzyl-L-glutamate) (PBLG)
Two grams of BLG-NCA (7.6 mmol) were dissolved in 25
mL of anhydrous dioxane. After cooling this solution to 4°C,
30.8 mg (0.354 mmol) triethylamine was added with vigor-
ous stirring. The mixture was stirred at room temperature
for 3 h, at which time the polymer was isolated by precipi-
tation in diethyl ether. The polymer was washed with a
mixture of dry acetone and diethyl ether and then separately
with diethyl ether. The final product, PBLG, was dried un-
15PHOTOINDUCED POLYMERIZATION OF HYDROGELS
der vacuum at room temperature. The yield was 1.0 g
(59.9%). 1H NMR (500 MHz, CDCl3) spectrum of the final
product shows:  8.30 (1H, NH), 7.27 (5H, C6H5), 5.61 (2H,
CH2), 3.97 (1H, CH), 2.60 and 2.28 (2H, CH2), 1.72 (1H, CH2)
ppm. And its 13C NMR (75.47 MHz, CDCl3):  25.75 (CH2),
31.05 (CH2), 57.09 (CH2), 66.37 (CH), 128.34, 128.68, 136.21
(Ar-C), 172.27, 175.63 (C=O) ppm.
PLG: Method (I)
Two and one-half grams of PBLG were dissolved in 250
mL of benzene. Hydrogen bromide was bubbled through
the solution at room temperature for about 90 min until the
solution turned to a gelatinous state. The mixture was al-
lowed to stand overnight. The solid was obtained by filtra-
tion and then washed thoroughly with methanol and diethyl
ether. The final debenzylated product, PLG, was dried un-
der vacuum. The yield was 1.32 g (89.8%). 1H NMR (300
MHz, DMSO-d6) spectrum of the product shows:  12.13
(1H, COOH), 8.10 (1H, NH), 3.87 (1H, CH), 2.24 (2H, CH2),
1.87 and 1.78 (2H, CH2) ppm. And its
13C NMR (75.47 MHz,
DMSO-d6):  173.67 (COOH), 65.01 (CH), 30.25 (CH2), 15.25
(CH2) ppm.
PLG: Method (II)
An alternative method was also attempted for de-
benzylation of PBLG. A 2N sodium hydroxide solu-
tion was added dropwise to a solution containing 1.0
g PBLG in 20 mL THF, while maintaining the solution
at room temperature. The mixture was then heated to
40°C for 2 h, followed by the removal of THF under
vacuum. The mixture was cooled to 4°C and then neu-
tralized with 0.1N HCl to a pH of 3.0. The white pre-
cipitate was collected by filtration. The product, PLG,
was washed repeatedly with water until the pH in the
rinsing solutions became neutral.
PEG-MA-graft-PLG
Before the hydrogel synthesis, PLG was modified by graft-
ing PEG-MA to the acidic side-groups of PLG by using a
variety of predetermined molar ratios of the acidic PLG
groups to PEG-MA. For example, PEG-MA-graft-PLG with
an acid:PEG-MA ratio of 5:1 was prepared by combining
0.10 g PLG (0.78 mmol glutamate monomer) and 32.2 mg
(0.156 mmol) dicyclohexylcarbodiimide (DCC) in 10 mL
N,N-dimethylformamide along with a three- to fivefold mo-
lar excess (relative to the moles of DCC) of PEG-MA and 5
mg (0.04 mmol) 4-dimethylaminopyridine (DMAP). After
stirring for 2 h at room temperature, the byproduct of this
reaction, 1,3-dicyclohexylurea, was removed by filtration.
The reaction mixture was then poured into 50 mL diethyl
ether in order to precipitate the final product, PEG-MA-
graft-PLG. After filtration, the product was washed with
methanol and diethyl ether to further remove any unreacted
PEG-MA. The PEG-MA-graft-PLG was then ready to use for
hydrogel synthesis without further drying. A small sample
of the product, however, was dried under vacuum for NMR
characterization. 1H NMR (300 MHz, F3CCOOH) spectrum
shows:  6.25 and 5.73 (=CH2), 4.72–−;3.80 (−CH2CH2−), 2.42
(CH2), 2.34 and 2.12 (CH2), and 1.94 (CH3) ppm.
PEG-DMA synthesis
PEG of the desired molecular weight (1000, 2000, or 3400
Da) was modified to the dimethacrylate derivative immedi-
ately before hydrogel synthesis. In brief, approximately 1.5
mmol PEG was dissolved with excess methacrylic acid (3.6
mmol) in about 30 mL of anhydrous methylene dichloride.
Excess coupling agent DCC (3.9 mmol) was added to this
solution along with 0.84 mmol DMAP. The solution was
stirred at room temperature for about 2 h at which time the
1,3-dicyclohexylurea byproduct was removed by filtration.
The resulting solution was evaporated to dryness under
vacuum. To facilitate removal of unreacted PEG and meth-
acrylic acid, the product was purified twice by recrystalli-
zation. First, the dried residue was dissolved in acetone,
filtered, and then precipitated into diethyl ether. The solid
collected from this procedure was then dissolved in methy-
lene chloride and the final PEG-DMA product was obtained
following precipitation using ethyl ether. The product was
collected, dried under vacuum, and stored in a dark con-
tainer under vacuum. 1H NMR (300 MHz, CDCl3) spectrum
shows:  6.13 and 5.58 (=CH2), 4.29 (−CH2−O2C−), 3.75
(OCH2C−O2C−), 3.67–3.64 [(OCH2CH2)n], and 1.95 (CH3)
ppm. One PEG-DMA (with a PEG molecular weight of
about 536 Da) was purchased commercially from Aldrich,




Hydrogels with different crosslinking density were syn-
thesized by crosslinking PEG-MA-graft-PLG with PEG-
DMA using equal moles of the methacrylate groups from
PEG-MA-graft-PLG and from PEG-DMA. In brief, the ex-
perimental procedures were performed by adding 25 mg
PEG-MA-graft-PLG and an appropriate molar equivalent of
PEG-DMA to 2 mL 0.01M phosphate buffer (pH 7.4) con-
taining 0.9 wt % sodium chloride. To this reaction mixture,
5 L of a solution containing 300 mg of 2,2-dimethoxy-2-
phenylacetophenone (i.e., the reaction initiator) in 1 mL of
N-vinyl-pyrrolidinone were added. Drug-loaded hydrogels
were prepared by adding the drug to this solution before the
crosslinking step. In these studies, about 5 g protein was
added per milligram of the hydrogel polymer constituents.
The polymer solution (either with or without drug) was then
placed into a cylindrical microsample tube (i.d. ∼6.5 mm)
and crosslinked by exposure to irradiation (11.6 mW/cm2)
at 365 nm using a B-100SP Model LWUV lamp (Fisher Sci-
entific). Gelation normally occurred after about 5 min of
irradiation. The hydrogels were rinsed with distilled water
several times, and then excess water from the surface of the
16 YANG ET AL.
samples was removed. The samples were cut into individual
cylinders ∼10 mm in length.
Swelling and hydrolysis studies
Swelling experiments were performed at several pH con-
ditions using different buffer solutions including the follow-
ing: (a) 0.01M citrate-buffered saline, pH 3.0, (b) 0.01M phos-
phate-buffered saline (PBS), pH 7.4, and (c) 0.01M boric acid-
buffered saline, pH 9.0. Swelling studies were carried out in
triplicate by placing dried hydrogel samples into a 20-mL
screw-capped glass vials containing 20 mL of appropriate
buffer solutions. The samples were maintained at 37.0°C in
a Precision Scientific Model 25 reciprocal-shaking bath (Chi-
cago, IL) and shaken at 60 cycles/min. At specific time in-
tervals, the hydrogel samples were removed from the solu-
tion, gently dried to remove excess liquid from the surface
and then weighed. The swelling ratio (SR) was estimated as
the ratio of the wet hydrogel (mwet) to the dry mass (mdry):
SR = mwet/mdry. (3)
Drug release studies
Drug release studies were performed in triplicate by plac-
ing dried, drug-loaded hydrogel samples into 20-mL screw-
capped glass vials containing 20 mL 0.01M PBS. The samples
were shaken continuously at 37°C. At selected time inter-
vals, the hydrogel samples were removed, gently dried,
weighed, and placed into new vials containing fresh buffer
solutions. The amount of the protein drug released at each
time interval was determined by using the Coomassie Plus
Protein Assay (Pierce, Rockford, IL). Calculations of the frac-
tional amount of drug released over time were made based
on the actual amount of drug that was added during the
preparation of the drug-loaded hydrogel.
RESULTS AND DISCUSSION
Synthesis and characterization
PBLG was synthesized in dry 1,4-dioxane by ring-
opening polymerization of BLG-NCA. The reaction
was initiated by triethylamine using a monomer-to-
initiator molar ratio of 25:1. Polymerization was car-
ried out at room temperature for 3 h according to the
method of Blout et al.12 The propagation reaction con-
sisted of a step-wise addition of BLG-NCA to the ter-
minal amino groups of the polymer chain. The degree
of polymerization was found to depend on several
factors including the monomer (BLG-NCA) concentra-
tion, initiator (triethylamine) concentration, reaction
time, and reaction temperature. For instance, a higher
molecular weight polymer could be obtained by using
a lower monomer concentration, longer reaction time,
and lower reaction temperature.
The molecular weights of the polymers used in this
study are listed in Table I. These results demonstrate
that NaOH debenzylation produced a greater loss in
polymer molecular weight than the HBr method. This
was probably caused by a rapid hydrolysis of the pep-
tide bond by the strong nucleophilicity of the hydrox-
ide ion.
As is outlined in Figure 1, PLG was modified to
permit photoinitiated crosslinking by attaching PEG-
MA groups to the free carboxyl side-chain groups of
PLG using the activating agent DCC. The 1H NMR
spectra in Figure 2 demonstrates the structures of the
PBLG, PLG, and PEG-MA-graft-PLG products. As
shown, the peaks of the benzyl group at 7.17–7.18 ppm
(phenyl) and 4.99–5.07 ppm (−CH2−) disappeared af-
ter debenzylation of PBLG. On the other hand, the
addition of PEG-MA to PLG introduced new signals at
5.73 and 6.25 ppm (=CH2), 3.80 ppm (−CH2−CH2−),
and 1.94 ppm (CH3), indicating a successful grafting of
this side-chain to the PLG polypeptide.
The synthesis of the crosslinker, PEG-DMA, was
performed using an excess molar ratio of the meth-
acrylic acid groups as well as the activator agent DCC
in order to facilitate conversion of the PEG to the dis-
ubstituted product. Two reprecipitations were per-
formed on the product, one using acetone and a sec-
ond with methylene chloride, in order to remove un-
reacted PEG and methacrylic acid. In this manner,
efforts were made to minimize the presence of unre-
acted or monosubstituted PEG. The PEG-DMA
crosslinker contains alkene bonds at both ends of the
PEG chain. Upon exposure to low wavelength UV ir-
radiation, these groups were capable of reacting with
the alkene groups on the PEG-MA-graft-PLG, result-
ing in crosslinking of the PLG backbone to form a
three-dimensional PLG-PEG hydrogel network. The
FTIR spectra of PLG and the PLG-PEG hydrogel are
shown in Figure 3. The spectrum of the hydrogel, in
comparison to that of the PLG, showed a new and
strong absorption band at about 1103 cm−1, represent-
ing the C−O−C stretching vibration of the attached
PEG chains. There was also an increase in the intensity
of bands at around 2876 and 2931 cm−1 (C−H stretch-
ing), which apparently were attributed to the intro-
duction of the PEG crosslinker into the hydrogel. Pho-
topolymerization proceeded very rapidly even though
no appreciable efforts were taken to minimize the
presence of oxygen before the reaction. As known,
TABLE I






78 kDa 25 kDa 11 kDa
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oxygen is usually an inhibitor to the free radical-
mediated polymerization. Typically, crosslinking took
place within 5 min of exposure to the radiation.
Swelling and hydrolysis behavior of the hydrogels
The swelling kinetics of hydrogels prepared using
different length of PEG crosslinkers was investigated
at pH 3.0, 7.4, and 9.0. As shown in Figure 4, all hy-
drogels exhibited a rapid initial hydration within the
first several hours of exposure to the aqueous envi-
ronment. This rapid hydration reflected the highly hy-
drophilic nature of the polymer constituents of this
hydrogel system. At pH 7.4, the gels imbibed >200%
water within the first hour of swelling.
The profiles seen in Figure 4 clearly demonstrate
that swelling increased significantly at higher pH lev-
els. This was attributed to the stronger electrostatic
repulsive force that was produced as the acidic PLG
side chains become increasingly ionized.13 Equilib-
rium swelling ratios at pH 7.4 were typically one-half
to two-fold higher than the values observed at pH 3.0.
Among the three hydrogel systems studied [Fig. 4(A–
C)], the greatest increase in equilibrium swelling oc-
curred at pH 9.0 with the hydrogel containing the
1000-Da PEG crosslinker. At this pH, the overall extent
of swelling was observed to decrease with increasing
PEG crosslinker molecular weight. As PEG molecular
weight increases, the relative number of acid groups
within a given weight of hydrogel will decrease. The
observations suggest that, in this instance, swelling
was primarily influenced by the number density of
ionized acid groups within the hydrogel rather than
the amount of hydrophilic ethylene oxide groups in
the PEG crosslinker.
Swelling experiments conducted over a longer pe-
riod of time provided evidence for the mechanism by
which this hydrogel system degraded. Figure 5 indi-
cated that hydrolytic degradation was base catalyzed,
as reflected by the significant increase in rate and ex-
tent of swelling that was observed at pH 9.0. After
Figure 2. Proton NMR spectra of PBLG, PLG, and PEG-
MA-graft-PLG.
Figure 1. Scheme used to prepare the PLG-PEG hydrogel
from the polypeptide, poly(-benzyl-L-glutamic acid),
PBLG.
Figure 3. FT-IR spectra of (a) PLG, (b) the PLG-PEG hy-
drogel.
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only 3 days at pH 9.0, hydrogel samples were already
degraded to viscous, solution (sol)-like gel. In contrast,
the gels swollen at pH 7.4 appeared to be relatively
stable for approximately 15 days. By day 23, however,
these samples were also degraded to a similar viscous
solution state as that attained after 3 days of exposure
to pH 9.0. On the other hand, gel samples maintained
at pH 3 were stable and retained their intact structure
throughout a 2-month period of study. The base-
catalyzed hydrolysis observed could be due to degra-
dation of the hydrolysis-susceptible amide bonds of
the polypeptide backbone and/or the ester bonds
formed between PLG and PEG. However, the rela-
tively rapid degradation under moderate pH (7.4) sug-
gests that hydrolysis of the ester bonds between PLG
and PEG may be the primary contributing factor to the
observed degradation.
Varying the density of the PEG-DMA crosslinker
appeared to be an effective method to manipulate the
molecular structure of the crosslinked hydrogel net-
work. Figure 6 depicts the swelling profiles of hydro-
gels prepared using acid/crosslinker ratios of 10:1, 5:1,
and 5:2. As seen, the hydrogel samples under study
displayed a greater swelling as the density of the
crosslinker decreased. An acid/crosslinker ratio of 5:2
resulted in a hydrogel with an equilibrium swelling
ratio of about 6 at pH 7.4, comparing to the value of 8
for the hydrogel prepared at a acid/crosslinker ratio
of 5:1. Moreover, a dramatically increase in the swell-
ing ratio was observed at the lowest crosslinker ratio
of 10:1. Obviously, a lower density of the crosslinkerFigure 4. Effects of the molecular weight of the crosslinker
on hydrogel swelling behavior at pH 3.0 (); 7.4 (□); and
9.0 (). Hydrogels were synthesized at a 10:1 crosslinker
ratio using (A) PEG-1000, (B) PEG-2000, and (C) PEG-3400.
Each experiment was conducted in triplicate, and error bars
represent the standard deviation.
Figure 5. Swelling behavior over time of PLG-PEG hydro-
gel prepared using the PEG-1000 crosslinker and at a
crosslinker ratio of 10:1 at pH 3.0 (), 7.4 (□), and 9.0 ().
Error bars represent the standard deviation of triplicate
samples.
Figure 6. Swelling characteristics at pH 7.4 of a PLG-PEG
hydrogel prepared using a PEG-536 crosslinker and a
crosslinker ratio of 10:1 (); 5:1 (□); and 5:2 ().
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would produce a hydrogel network with a greater dis-
tance between polymer chains, rendering the network
less resistant to electrostatic and hydrophilic swelling
forces.
These findings suggest that either the number den-
sity or molecular weight of the crosslinker can be used
to manipulate the degree of swelling of the hydrogel.
Consequently, these factors also represent possible
means to regulate the effective release rate of the drug
entrapped within the hydrogel network.
In vitro protein release studies
The release of several model proteins was investi-
gated using hydrogels prepared with the 536-Da PEG-
DMA crosslinker at acid/crosslinker ratios of 10:1, 5:1,
and 5:2. Figure 7 shows the release profiles of insulin,
lysozyme, and albumin; a group of proteins that rep-
resent a broad range of molecular weights (5,800,
14,300, and 66,400 Da, respectively). A rapid release
during the first 16 h, which was relatively indepen-
dent on the molecular weight of the protein, was ob-
served for all these three proteins. This relatively con-
stant drug release during the initial period was likely
attributed to a burst release of the drug that was avail-
able at the hydrogel surface before the swollen gel
barrier was established. After 16 h and longer, how-
ever, release rates were influenced by the molecular
weight of the protein drug as well as the density of the
crosslinker in the hydrogel network. For instance,
smaller proteins such as insulin displayed relatively
rapid release. Indeed, insulin release was nearly com-
plete within about 2.5 days from hydrogels with
crosslinker ratios of 10:1 and 5:1. In contrast, a com-
plete release of lysozyme required at least 10 days,
whereas during the same span of time, release of al-
bumin was only about 40–60%. On the other hand, all
protein release was prolonged using hydrogels con-
taining higher crosslinker ratios. At the highest
crosslinker ratio, the duration of insulin release was
doubled to about 5 days and a similar trend was ob-
served for both lysozyme and albumin. Overall, in-
creasing the crosslinker density resulted in a reduction
in drug release rate from the hydrogel network.
The synthesis of the described hydrogel network by
photoinitiated crosslinking in the presence of the drug
compounds offers several potential advantages. First,
crosslinking of the polymer can be achieved specifi-
cally without the possibility that the drug itself may
also be covalently linked to the polymer matrix during
the crosslinking process. Second, unlike loading the
drug by the conventional swelling/absorption mecha-
nism where steric hindrance could result in heteroge-
neous drug loading and distribution, a consistent drug
loading could be obtained for the described hydrogel
system. Last but not least, manipulation of the
crosslinker density can be used to achieve a desirable
and regulated drug release rate.
CONCLUSIONS
In summary, a novel polypeptide hydrogel system
composed of PLG as the polymer backbone and PEG
Figure 7. Drug release profiles from PGA-PEG hydrogels
prepared using the PEG-536 crosslinker and crosslinker ra-
tios of 10:1 (), 5:1 (□), and 5:2 (). Release experiments
were performed in 0.01M PBS (pH 7.4) at 37°C using (A)
insulin, (B) lysozyme, and (C) albumin. Error bars represent
the standard deviation of triplicate samples.
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as the crosslinker was synthesized using a photoiniti-
ated crosslinking chemistry. Similar to our earlier
PLG-PEG polypeptide hydrogel,13 which was synthe-
sized by conventional crosslinking chemistry, this hy-
drogel also showed a pH-responsive swelling behav-
ior. Changes in the crosslinker density and the chain
length influenced the swelling characteristics of these
hydrogel systems. Unlike the polypeptide hydrogel
system previously developed,13 this new crosslinked
hydrogel system, because of the introduction of ester
bonds into the crosslinking scheme, was degradable
by hydrolysis over a time span and pH conditions that
were practically required. Because this hydrogel could
be synthesized directly in the presence of the drug
compound, high drug loading could be readily
achieved. In vitro release studies demonstrated that
the molecular weight of the entrapped drug would
influence its release rates, and modification of hydro-
gel network structure could be used directly to regu-
late the drug release profile.
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